Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
March 05 2018 - 4:01PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present
corporate updates at two upcoming investor conferences in
March:
- 2018 Cowen and Company 38th Annual
Health Care Conference on Monday, March 12, 2018 at 11:20 a.m. ET
at The Boston Marriott Copley Place in Boston.
- Barclays Global Healthcare Conference
on Thursday, March 15, 2018 at 10:15 a.m. ET at the Loews Miami
Beach Hotel in Miami.
A live webcast of Ironwood’s presentations will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. To access the webcasts, please log on to
the Ironwood website approximately 15 minutes prior to the start
time to ensure adequate time for any software downloads that may be
required. A replay of the webcasts will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ:IRWD) is a commercial
biotechnology company focused on creating medicines that make a
difference for patients, building value for our fellow
shareholders, and empowering our passionate team. We are
commercializing two innovative primary care products: linaclotide,
the U.S. branded prescription market leader for adults with
irritable bowel syndrome with constipation (IBS‐C) or chronic
idiopathic constipation (CIC), and lesinurad, which is approved for
the treatment of hyperuricemia associated with gout in patients who
have not achieved target serum uric acid (sUA) levels with a
medically appropriate daily dose of a xanthine oxidase inhibitor
(XOI) alone. We are also advancing a pipeline of innovative product
candidates in areas of significant unmet need, including
uncontrolled gastroesophageal reflux disease, diabetic nephropathy,
heart failure with preserved ejection fraction, achalasia and
sickle cell disease. Ironwood was founded in 1998 and is
headquartered in Cambridge, Mass. For more information, please
visit www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180305006122/en/
Ironwood Pharmaceuticals, Inc.Meredith Kaya, 617-374-5082Vice
President, Investor Relations and Corporate
Communicationsmkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Apr 2023 to Apr 2024